Interferon beta-1a SubQ injection Treatment Evaluations
Most Popular Brands: Rebif
One of 58 patient evaluations for Interferon beta-1a SubQ injection
-
- JAKEVANNIE
- Sex: F
- Data Quality: 1 star
- MS: 5 yrs
- Relapsing-Remitting
- Sensation: Moderate
- Overall: Moderate
- Cognition: moderate
- Vision: mild
- Speech: moderate
- Swallowing: none
- Upper limb: moderate
- Walking: moderate
- See profile
-
- by JAKEVANNIE
- current dosage:
- 3 x 22 mcg/0.5 mL weekly
- time on dosage:
- about 1 day
- purpose:
- General health
-
| General health Efficacy | Side Effects | Adherence | Burden | Specific Side Effects | |
|---|---|---|---|---|---|
| Dec 31, 2008 |
Slight
|
Mild
|
Always
|
A little
|
|
-
0 helpful marks